Author

V. Levin-Salomon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:metagenomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Kimchi· 2 shared N. P. Dekel-Bird· 2 shared N. Yaeli-Slonim· 2 shared S. Bialik· 2 shared A. Savidor· 1 shared B. Geiger· 1 shared L. Hammer· 1 shared M. Besser· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Kimchi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivFeb 17, 2021

The Serine Protease HtrA2 mediates radiation-induced senescence in cancer cells

L. Hammer, V. Levin-Salomon, N. Yaeli-Slonim…·A. Kimchi

This study identifies HtrA2 as a mediator of radiation-induced senescence in cancer cells, showing its role in proliferation arrest and vimentin filament reorganization.

DOI 10.1002/1878-0261.13187

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivNov 11, 2020

A functional pre-screening platform for identifying points of vulnerability in the cell death map of human melanoma tumors

N. P. Dekel-Bird, S. Bialik, O. Itzhaki…·A. Kimchi

The paper develops a prescreening platform to identify tumor-specific vulnerabilities in melanoma cell death networks, improving targeted therapy by reducing drug resistance and relapse.

DOI 10.26502/jcsct.5079145

humanproteomics

𝕏 PostBluesky